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Asian dust, known as kosa in Japanese, is a major public health concern. In this panel 
study, we evaluated the effects of exposure to kosa on daily cough occurrence. The study 
subjects were 86 patients being treated for asthma, cough variant asthma, or atopic cough in 
Kanazawa University Hospital from January 2011 to June 2011. Daily mean concentrations of 
kosa and spherical particles were obtained from light detection and ranging (LIDAR) 
measurements, and were categorized from Grade 1 (0 μg/m3) to 5 (over 100 μg/m3). The 
association between kosa and cough was analyzed by logistic regression with a generalized 
estimating equation. Kosa effects on cough were seen for all Grades with potential time lag 
effect. Particularly at Lag 0 (the day of exposure), a dose-response relationship was observed: 
the odds ratios for Grades 2, 3, 4, and 5 above the referent (Grade 1) were 1.111 (95% 
confidence interval (CI): 0.995–1.239), 1.171 (95% CI: 1.006–1.363), 1.357 (95% CI: 1.029–
1.788), and 1.414 (95% CI: 0.983–2.036), respectively. Among the patients without asthma, the 
association was higher: the odds ratios for Grades 2, 3, 4 and 5 were 1.223 (95% CI: 0.999–
1.497), 1.309 (95% CI: 0.987–1.737), 1.738 (95% CI: 1.029–2.935) and 2.403 (95% CI: 1.158–
4.985), respectively. These associations remained after adjusting for the concentration of 
spherical particles or particulate matter with an aerodynamic diameter of less than 2.5 μm 
(PM2.5). Our findings demonstrate that kosa is an environmental factor which induces cough in a 





1. Introduction  
 
The desert dust storms are major contributors to the atmospheric particulate matter 
(PM) with an aerodynamic diameter of less than 10 μm (PM10). The adverse health effects of 
desert dust are demonstrated in many reports; The desert dust have relation with cardiac and 
respiratory mortality (Barnett et al., 2012; Jimenez et al., 2010; Mallone et al., 2011; Perez et al., 
2012) and daily hospitalization (Alessandrini et al., 2013). Asian dust, known as kosa in 
Japanese, originates from the Taklamakan and Gobi deserts and the Loess plateau of interior 
China. The dust is then blown eastwards by the westerly winds to countries such as Korea, 
Taiwan and Japan (Iwasaka et al., 2003; Minoura et al., 1998). Epidemiological studies show 
that kosa decreases peak expiratory flow values in patients with asthma (Park et al., 2005), and 
increases the number of hospitalizations and emergency visits through exacerbation of asthma 
(Kanatani et al., 2010; Yang et al., 2005). These findings are supported by experimental studies 
in which kosa inhalation enhanced allergen-induced airway inflammation in mouse models 
(Hiyoshi et al., 2005; Ichinose et al., 2008; Lei et al., 2004).  
Asthma is a chronic inflammatory airway condition characterized by repetitive 
coughing, wheezing, dyspnea, reversible airway narrowing, and airway hyperresponsiveness 
(Ohta et al., 2011). The prevalence of asthma amongst Japanese adults has increased over the 
past decade (Fukutomi et al., 2010), and the number of patient suffering from chronic cough 
without wheezing or dyspnea has also increased in recent years. In Japan, most patients in the 
latter group are diagnosed with either cough variant asthma or atopic cough (Fujimura et al., 
2005). Cough variant asthma is a precursor of asthma (Corrao et al., 1979; Irwin et al., 1997), 
whereas atopic cough is defined as a non-asthmatic bronchodilator-resistant chronic cough 
associated with atopy (Fujimura et al., 1992).  
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Chronic cough can result from hypersensitivity to environmental factors such as 
chemicals, cold air, and smoke (Matsumoto et al., 2012; Ternesten-Hasseus et al., 2011). Our 
preliminary data indicate that there are significantly more cough-positive patients during kosa 
period than non-kosa period among the adult patients with asthma, cough variant asthma, or 
atopic cough (Higashi et al., in press). In the present study, we assessed the relationship between 






We enrolled adult patients with physician-diagnosed at least one of asthma, cough 
variant asthma, or atopic cough between January 2011 and June 2011 at the Kanazawa 
University Hospital, Ishikawa Prefecture, Japan. This study was approved by the Medical Ethics 
Committee of Kanazawa University. All patients gave informed consent before participating in 
the study.   
Asthma was diagnosed on the basis of the Japan Asthma Prevention and Management 
Guidelines 2011 (Ohta et al., 2011). Cough variant asthma was diagnosed using the criteria of 
the Japanese Cough Research Society (Kohno et al., 2006). Atopic cough was diagnosed 
according to previously reported criteria (Fujimura et al., 1992), which are based on 
bronchodilator-resistant cough and the resolution of the cough with the use of histamine H1 
antagonists and/or inhaled corticosteroids (ICS).  
Patients continued to take their usual medications, according to the standard medical 
treatment of each disease during the study period. Patients with asthma and cough variant 
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asthma took medications such as bronchodilator and/or ICS, and patients with atopic cough took 
medications such as histamine H1 antagonists and/or ICS. No patient experienced symptoms 
suggestive of chronic obstructive pulmonary diseases or other potentially confounding 




At the first consultation day during the study period, each patient was required to 
record his/her symptoms in a cough diary every day. The time period of study for each patient 
was from his/her first consultation day to the end of the study, June 30 for all. To prevent 
patients dropout based on lack of recording, we asked the patients to show their diary to the 
doctor when they visited the hospital during the study period. We used the data regarding the 





The daily mean concentrations of kosa and spherical particles were estimated as 
described previously (Onishi et al., 2012). Briefly, we used the dust extinction coefficient and 
the sphere extinction coefficient derived from light detection and ranging (LIDAR) system with 
a polarization analyzer which distinguishes mineral dust particles that are non-spherical, 
including kosa, from spherical particles by identifying the differences in the shape of the 
particles (Iwasaka et al., 2004; Shimizu et al., 2004; Sugimoto et al., 2011). We used the data at 
the Toyama monitoring station (Imizu City, Toyama Prefecture, Japan) which is the nearest, 
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approximately 40 km east, from Kanazawa City. To obtain the daily near-surface extinction 
coefficients, the 6 h median values in 120- 1000 m height areas were averaged over 24 h. The 
concentrations of kosa and spherical particles were calculated by conversion factors from the 
dust extinction coefficient and the sphere extinction coefficient, respectively (Shimizu et al., 
2011; Sugimoto et al., 2013). 
The concentrations of particulate matter with an aerodynamic diameter of less than 2.5 
μm (PM2.5) were monitored at a Mattou monitoring station (Hakusan City, Ishikawa Prefecture, 
Japan) which is the nearest, approximately 15.5 km west, from Kanazawa City. The temperature 
and rainfall were measured continuously at a Kodatsuno monitoring station in Kanazawa City.  
 
2.4 Data Analysis 
 
To evaluate the effects of kosa on cough, we used logistic regression with a 
generalized estimating equation which is suitable for correlated data in individuals (Janes et al., 
2008; Jennrich and Schluchter, 1986; Liang and Zeger, 1986), according to previous reports 
(Cesaroni et al., 2008; Gehring et al., 2010; Ma et al., 2008). Briefly, in the model of,  
logit P (Yit = 1/Xit) = β0 + βM Xit,  
Yit represent the binary outcome, population average occurrence of cough, for subject i at time t, 
and Xit represent kosa level at time t. In a marginal model, P(Yit = 1/Xit) represent the 
occurrence of cough as a function of the kosa level (Janes et al., 2008; Leisenring et al., 1997; 
Martus et al., 2004). The marginal parameter, βM, was estimated using generalized estimating 
equation with independent working correlation and robust standard errors. We categorized the 
kosa concentration into five grades as follows: Grade 1, equated to 0 μg/m3; Grade 2, 0–10 
μg/m3; Grade 3, 10–30 μg/m3; Grade 4, 30–100 μg/m3; and Grade 5, over 100 μg/m3. It was 
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reported that the standard threshold of the dust concentration for an Asian dust day was 100 
μg/m3 (Sugimoto et al., 2003). Besides these days, the typical kosa days were identified as 
increase in the LIDAR signal of more than 30μg/m3 in this study period. We used these values 
for setting up the grades of kosa concentration. The odds ratios (ORs) with 95% confidence 
intervals (CIs) were calculated relative to the referent level (Grade 1) after adjustment for sex, 
age, body mass index (BMI), temperature, and rain. In addition, seasonality was included in the 
model as categorical variables: winter (January and February) and spring (from March to June). 
The concentration of spherical particles and PM2.5 were categorized into quartiles and the ORs 
with 95% (CIs) were calculated above the referent (first quartile). The time lag from the 
exposure to cough occurrence was taken into consideration (Lag 0 – Lag 3). Two-pollutant 
model included sex, age, body mass index (BMI), temperature, rain, seasonality, kosa, and 
spherical particles or PM2.5. All statistical analyses were performed using the SPSS
® 19.0 




3.1 Descriptive Statistics 
 
Of 104 patients aged 23–84 years who gave informed consent, 90 (86.5%) completed 
the cough diary, and were enrolled in our study. However, we excluded four patients because 
they were current smokers. Therefore, we studied 86 adults (28 males and 58 females) with a 
mean ± standard deviation (SD) age of 64.0 ± 12.7 years and a physician- diagnosis of at least 
one of the following conditions: asthma, cough variant asthma, or atopic cough (Table 1). We 
compared the subgroups of subjects with and without a diagnosis of asthma. Subgroups with 
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asthma consisted of 49 patients with asthma and 4 patients with asthma and atopic cough. Of 33 
subjects without asthma, eight, 15, and 10 patients were diagnosed with cough variant asthma, 
atopic cough, and cough variant asthma and atopic cough, respectively. The age distribution, 
gender ratio and BMI were not different between two subgroups. The prevalence of cough was 
significantly different between two subgroups with medians of 7.8 (interquartile range (IQR), 
32.2) and 66.7 (IQR, 72.7) in subjects with and without asthma, respectively (p< 0.001, Table 1). 
Throughout the study period, the daily prevalence of cough was higher in subjects without 
asthma than with asthma, as shown in Figure 1A. 
The daily concentrations of dust (kosa) particles, spherical particles and PM2.5 during 
the study period are shown in Figure 1B. Typical large-scale kosa events were identified on 
May 2, 3 and 13 as remarkable increase in the LIDAR signal (>100μg/m3; Grade 5) as 
shown in Figure 1B. Increases in the dust concentration (30-100 μg/m3; Grade 4) were 
also observed 12 days such as April 10 to 15 and May 14 to 16. Weak increases in the 
dust concentration (10 -30 μg/m3; Grade 3) were recorded for 46 days. In these days of 
Grade 5, 4, and 3, 91.5%, 93.2% and 86.1% of the subjects recorded their diaries, 
respectively. The concentration of dust (kosa) particles correlated with the concentration of 
spherical particles and PM2.5 with Pearson’s correlation coefficients of 0.252 (p< 0.001, Figure 
2A) and 0.519 (p< 0.001, Figure 2B), respectively. At the extremely high kosa days 
(>100μg/m3; Grade 5), the concentration of PM2.5 correlated with the dust (kosa) particles, 
although spherical particles had no correlation (Figure 2).  
 
3.2. Cough and Exposure to Particulate Matters 
 
To analyze the relationship between kosa levels and cough occurrence, the 
8 
 
concentrations of kosa were categorized into five grades. The adjusted ORs with 95% CIs of 
cough occurrence, as calculated relative to the lowest level (Grade 1) of kosa concentration 
using single-pollutant models adjusted for sex, age (years), BMI, temperature, rain, and 
seasonality were shown in Table 2. Kosa concentrations were significantly associated with 
cough occurrence on the day of exposure (Lag 0) in total subjects following a dose-response 
manner, with ORs for Grade 2, 3, 4, and 5 of 1.111 (95% CI: 0.995–1.239), 1.171 (95% CI: 
1.006–1.363), 1.357 (95% CI: 1.029–1.788), and 1.414 (95% CI: 0.983–2.036), respectively. 
The ORs in subjects without asthma were higher than in total subjects; the ORs for Grade 2, 3, 4 
and 5 were 1.223 (95% CI: 0.999–1.497), 1.309 (95% CI: 0.987–1.737), 1.738 (95% CI: 1.029–
2.935) and 2.403 (95% CI: 1.158–4.985), respectively. On the other hand, association was not 
observed between kosa and cough symptoms among subjects with asthma. The time lag effect 
from kosa exposure to cough occurrence was observed for one day following exposure (Lag 1) 
and up to three days following exposure (to Lag 3), although the ORs for Lag 1-3 were lower 
than for Lag 0 in total subjects and subjects without asthma (Table2).  
Similarly, the relationship between spherical particle level and cough occurrence were 
analyzed. Subjects without asthma were more likely to have association with cough from Lag 0 
to Lag 2 (Table 3), whereas the values of ORs were lower than ORs for kosa exposure. Subjects 
with asthma characteristically exhibited association with cough at Lag 3; the ORs for 2nd, 3rd 
and 4th compared to reference (1st) were 1.023 (95% CI: 0.912–1.148), 1.193 (95% CI: 1.004–
1.418) and 1.245 (95% CI: 1.020–1.519), respectively (Table 3). When we analyzed the 
relationship between PM2.5 and cough, the association was evidently observed among subjects 
without asthma at Lag 0 with statistically significant interaction; the ORs for 2nd, 3rd and 4th 
were 1.271 (95% CI: 1.043–1.548), 1.267 (95% CI: 1.019–1.574) and 1.411 (95% CI: 1.101–
1.808), respectively (Table 4).  
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Then, we investigated whether cough occurrence was dependent on the quantity of 
kosa or other spherical particles and PM2.5. The effects of kosa on cough on the day of exposure 
(Lag 0) were similar in two-pollutant models adjusting for presence of spherical particles 
(Figure 3A): ORs of subjects without asthma for Grade 2, 3, 4, and 5 were 1.196 (95% CI: 
0.898–1.594), 1.260 (95% CI: 0.909–1.747), 1.738 (95% CI: 0.981–3.081) and, 2.260 (95% CI: 
1.032–4.953), respectively.  And, while somewhat attenuated, the effects of kosa on cough 
were also suggestive in two-pollutant models adjusting for PM2.5 (Figure 3B): ORs of subjects 
without asthma for Grade 2, 3, 4, and 5 were 1.208 (95% CI: 0.989–1.476), 1. 272 (95% CI: 
0.978–1.653), 1.631 (95% CI: 0.984–2.7041), and 2.198 (95% CI: 1.079–4.479), respectively. 
These results indicate that adversely kosa effect on cough was independent of other spherical 




The main aim of this study was to evaluate the relationship between exposure to kosa 
and cough occurrence in adult patients suffering from at least one of the following: asthma, 
cough variant asthma, or atopic cough. We demonstrated a significant association between kosa 
and cough in patients with chronic cough. This association was particularly high among subjects 
without asthma, whereas no association was found in subjects with asthma. With respect to 
patients with asthma, our findings were consistent with a previous panel study which reported 
no association between kosa and cough among patients with asthma in Korea (Park et al., 2005). 
In this study, the subjects without asthma consisted of patients with cough variant asthma and/or 
atopic cough. As far as we know, this is the first study to demonstrate the dose-response relation 
between kosa exposure and cough occurrence in patient with cough variant asthma and/or atopic 
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cough. A cross-sectional study showed that more than 60% of patients with chronic unexplained 
cough reported that coughing was induced by environmental factors and that this had a negative 
impact on health status and daily life (Ternesten-Hasseus et al., 2011). These factors included 
chemicals, scents, exercise, and cold air. Our findings showed that in addition to these, kosa is 
an environmental factor that can induce cough among patients with chronic cough.  
In our assessment of the health effects of dust, data were measured with the LIDAR 
system, which distinguishes mineral dust particles from spherical particles by identifying the 
differences in the shape of the particles (Shimizu et al., 2011; Sugimoto et al., 2013). Thus, it 
can specifically estimate each concentration of kosa and spherical particles (Shimizu et al., 
2011; Sugimoto et al., 2013). Because spherical particles and PM2.5 adversely affect respiratory 
diseases (Brunekreef et al., 1995; Dockery et al., 1993; Peng et al., 2008; Pope et al., 1995), it 
remains unclear whether adverse effects in Asian dust days are dependent on the quantity of 
kosa or other particles. In this study, we clearly demonstrated that kosa effect on cough was 
independent of other particles in two-pollutant model adjusting for spherical particles or PM2.5, 
whereas association between cough and spherical particles or PM2.5 was observed in 
single-pollutant model. However, there is a limitation of the assessment of exposure. Because 
observation stations of LIDAR and PM2.5 were limited, we used the data at the nearest stations 
from Kanazawa city. There was possibility that data at the observation station was not always 
reflective of the concentration of study area and the individual exposures. 
Time series analyses have shown that kosa is associated with the mortality of 
circulatory and respiratory diseases (Kashima et al., 2012), hospitalization for cerebrovascular 
disease (Bell et al., 2008), and the variability of peak expiratory flow values in patients with 
asthma (Park et al., 2005) in a dose-response manner. However, an association has not been 
established regarding cough. We have shown that kosa also affects cough among patients with 
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chronic cough in a dose-response manner. The Japan Meteorological Agency defines a kosa 
day—the occurrence of a kosa event—as a day when visibility is <10 km in a Japanese city. The 
standard threshold of dust concentrations for a kosa day is approximately 100 μg/m3. We 
demonstrated that adverse respiratory symptoms increased at levels of exposure as low as 10–30 
μg/m3, which are not detectable by visible observation. This represents an important, and 
potentially manageable, public health issue.  
A time lag occurs when surveying patients who visit the hospital because most 
patients visit the hospital the day after exposure, when the majority of severe symptoms are 
relieved. However, we were able to eliminate this effect in the present study by using cough 
diaries that were recorded on the day of exposure. The data obtained from these diaries clarified 
that exposure to kosa induces cough on the same day of exposure (Lag 0). In addition, the cough 
remained association with kosa for up to three lag days, indicating prolonged effects of kosa.  
In this study, patients had different comorbidities and continued to take their usual 
medications, according to the standard medical treatment of each disease. The severity of 
disease status and medication use may have effects on the cough symptoms and act as 
confounders. Our study subjects included the patients who had no cough symptoms throughout 
the study period, implying the possibility that there are missing covariate data which ignores 
subjects with incomplete information. It may be necessary to approach in other models 
including missing covariates (Janssen et al., 2010; Lipsitz et al., 1999). Moreover, confirmation 
of whether symptoms vary with asthma, cough variant asthma, and atopic cough, and the 
determination of additional environmental factors that adversely affect these respiratory diseases, 
including chemical factors, metals, pollens, and microorganism, (Maki et al., 2010; Onishi et al., 




5. Conclusions  
 
A dose-response relationship between kosa and daily cough occurrence and potential 
lag effects were observed in this study. Adversely kosa effect on cough was independent of 
other spherical particles or PM2.5. Our findings demonstrated that kosa is an environmental 
factor which induces cough in patients with chronic cough, especially with cough variant 
asthma and/or atopic cough. 
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Figure 1. The daily cough prevalence among total subjects, subjects with and without a 
diagnosis of asthma (A) and daily concentrations of airborne particulate matter during 
the study period (B). 
 
Figure 2.  Scatter plots of Dust (kosa) particles and Spherical particles (A) and PM2.5 
(B). *: p< 0.001, Pearson’s correlation coefficient  
 
Figure 3. Adjusted odds ratios (ORs) for relationship between cough symptoms and 
concentration of Dust (kosa) particles on the day of exposure (Lag 0) in the 
two-pollutant model with spherical particles (A) and PM2.5 (B). The model includes sex, 
age, BMI, temperature, rain, seasonality, kosa and spherical particles (A) and PM2.5 (B).  
ORs are estimated by using generalized estimating equations with independent 
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Figure 3. Adjusted odds ratios (ORs) for relationship between cough symptoms and 
concentration of Dust (kosa) particles on the day of exposure (Lag 0) in the 
two-pollutant model with spherical particles (A) and PM2.5 (B). The model includes sex, 
age, BMI, temperature, rain, seasonality, kosa and spherical particles (A) and PM2.5 (B).  
ORs are estimated by using generalized estimating equations with independent 
working correlation. Error bars represent 95% confidence intervals. 
Table１．Characteristics of the study subjects
   Total subjects Subjects with Asthma Subjects without Asthma  
 (n = 86)  (n = 53) (n = 33) 
Age (years) 64.0 ± 12.7 65.7 ± 12.0 61.1 ± 13.4
Gender
　　Male 28 (32.6) 19 (35.8) 9 (27.3)
　　Female 58 (67.4) 34 (64.2) 24 (72.7)
BMI (kg/m2) 22.8 ± 3.3 22.7 ± 2.8 22.9 ± 4.0
Disease 
　　Asthma 49 (57.0) 49 (92.5) -
　　CVA 8 (9.3) - 8 (24.2)
　　AC 15 (17.4) - 15 (45.5)
　　Asthma and AC 4 (4.7) 4 (7.5) -
　　CVA and AC 10 (11.6) - 10 (30.3)
Disease duration (years) 15.6 ± 9.4 17.9 ± 9.8 12.1 ± 7.6
Smoking status
　　non-smoker 60 （69.8) 32 （60.4) 28 （84.8)
　　ex-smoker 26 (30.2) 21 (39.6)  5 (15.2)
Number of recorded days 124.9 ± 51.0 142.5 ± 39.5 96.7 ± 55.0
Prevalence of cough  (%)*
　　Mean ± SD 35.9 ± 36.9 22.6 ± 30.8 57.2 ± 36.3
　　Median (IQR, range)† 20.3 (65.3, 0-100) 7.8 (32.2, 0-100) 66.7 (72.7, 0-100)
Time period of study (day)** 134.9 ± 22.2 142.4 ± 17.7 122.8 ± 23.7
Data are presented as the no (%) or mean ± SD.
CVA, cough variant asthma; AC, atopic cough
* (Number of days with cough)/ (Number of recorded days)
**  From the entry (the first consultation day during study period for each subject) to the end of study (30 June for all)
†: p < 0.001, with Asthma vs. without Asthma, by Mann-Whitney's U test
Table 2.
Total subjects (n = 86) Subjects with Asthma (n=53) Subjects without Asthma (n=33)†
OR† 95% Cl OR† 95% Cl OR† 95% Cl
Lag 0
Dust (μg/m3)
Grade 5: 100 - 3 1.414 0.983 2.036 0.981 0.547 1.759 2.403 1.158 4.985 *
Grade 4:  30 -100 12 1.357 1.029 1.788 * 1.186 0.811 1.735 1.738 1.029 2.935 *
Grade 3:  10 -30 46 1.171 1.006 1.363 * 1.084 0.875 1.344 1.309 0.987 1.737
Grade 2:   -10 84 1.111 0.995 1.239 1.062 0.914 1.236 1.223 0.999 1.497
Grade 1:    0 33 1 1 1
Lag 1
Dust (μg/m3)
Grade 5: 100 - 3 1.261 0.853 1.864 1.366 0.797 2.343 1.139 0.565 2.295
Grade 4:  30 -100 12 1.284 0.977 1.688 1.128 0.788 1.614 1.567 0.931 2.638
Grade 3:  10 -30 46 1.209 1.043 1.402 * 1.034 0.846 1.262 1.511 1.159 1.971 *
Grade 2:   -10 84 1.145 1.020 1.284 * 1.086 0.923 1.277 1.250 1.023 1.527 *
Grade 1:    0 33 1 . . 1 . . 1 . .
Lag 2
Dust (μg/m3)
Grade 5: 100 - 3 0.986 0.675 1.439 0.712 0.399 1.270 1.261 0.591 2.691
Grade 4:  30 -100 12 1.239 0.950 1.617 1.165 0.819 1.657 1.346 0.797 2.273
Grade 3:  10 -30 46 1.155 0.995 1.342 1.065 0.872 1.300 1.264 0.926 1.725
Grade 2:   -10 84 1.066 0.950 1.197 1.091 0.916 1.301 0.988 0.809 1.208
Grade 1:    0 33 1 . . 1 . . 1 . .
Lag 3
Dust (μg/m3)
Grade 5: 100 - 3 1.267 0.917 1.749 1.029 0.592 1.787 1.655 0.939 2.916
Grade 4:  30 -100 12 1.333 1.025 1.733 * 1.338 0.973 1.840 1.369 0.796 2.352
Grade 3:  10 -30 46 1.132 0.973 1.318 1.125 0.913 1.386 1.115 0.821 1.513
Grade 2:   -10 84 1.077 0.977 1.188 1.101 0.956 1.268 1.032 0.856 1.245
Grade 1:    0 33 1 . . 1 . . 1 . .
* : p  < 0.05
†: Adjusted odds ratios (ORs) and 95% confidence intervals (Cls) for cough symptoms relative to the concentration of dust
(kosa ), adjusted for sex, age, BMI, temperature, rain and seasonality.
number
of days
Adjusted odds ratios and 95% confidence intervals for cough symptoms associated with Dust (kosa ) concentration at
various exposure lags in the single-pollutant model
Table 3.
Total subjects (n = 86) Subjects with Asthma (n=53) Subjects without Asthma (n=33)†
OR† 95% Cl OR† 95% Cl OR† 95% Cl
Lag 0
Sphere (quartiles, μg/m3)
4th:  70.5 -248.2 1.135 0.987 1.304 1.033 0.855 1.248 1.293 0.979 1.707
3rd:  40.3 -70.5 1.045 0.928 1.177 0.965 0.805 1.157 1.152 0.933 1.421
2nd:   1.3 -40.3 1.078 0.978 1.190 1.014 0.884 1.163 1.205 0.998 1.455
1st:    0.0 -1.3 1 . . 1 . . 1 . .
Lag 1
Sphere (quartiles, μg/m3)
4th:  70.5 -248.2 1.197 1.036 1.382 * 1.131 0.928 1.378 1.299 0.993 1.699
3rd:  40.3 -70.5 1.167 1.043 1.306 * 1.146 0.958 1.371 1.219 1.020 1.458 *
2nd:   1.3 -40.3 1.156 1.042 1.281 * 1.096 0.957 1.255 1.270 1.024 1.575 *
1st:    0.0 -1.3 1 . . 1 . . 1 . .
Lag 2
Sphere (quartiles, μg/m3)
4th:  70.5 -248.2 1.154 1.010 1.319 * 1.141 0.947 1.375 1.173 0.900 1.529
3rd:  40.3 -70.5 1.098 0.985 1.225 1.129 0.941 1.354 1.050 0.892 1.235
2nd:   1.3 -40.3 1.050 0.971 1.136 1.025 0.928 1.133 1.066 0.891 1.275
1st:    0.0 -1.3 1 . . 1 . . 1 . .
Lag 3
Sphere (quartiles, μg/m3)
4th:  70.5 -248.2 1.200 1.043 1.380 * 1.245 1.020 1.519 * 1.174 0.903 1.527
3rd:  40.3 -70.5 1.141 1.022 1.272 * 1.193 1.004 1.418 * 1.065 0.886 1.280
2nd:   1.3 -40.3 1.090 0.995 1.194 1.023 0.912 1.148 1.186 0.972 1.447
1st:    0.0 -1.3 1 . . 1 . . 1 . .
* : p  < 0.05
Adjusted odds ratios and 95% confidence intervals for cough symptoms associated with  concentration of  spherical
particles (Sphere) at various exposure lags in the single-pollutant model
†: Adjusted odds ratios(ORs) and 95% confidence intervals (Cls) for cough symptoms relative to the concentration of  spherical particles, adjusted for, sex, age, BMI,
temperature, rain and seasonality.
Table 4.
Total subjects (n = 86) Subjects with Asthma (n=53) Subjects without Asthma (n=33)†




4th:  17.3 -48.0 1.218 1.067 1.392 * 1.147 0.962 1.368 1.411 1.101 1.808 *
3rd:  11.9 -17.3 1.105 0.992 1.231 1.035 0.898 1.193 1.267 1.019 1.574 *
2nd:   7.8 -11.9 1.082 0.987 1.187 0.998 0.890 1.118 1.271 1.043 1.548 *




4th:  17.3 -48.0 1.147 0.990 1.328 1.092 0.904 1.319 1.249 0.927 1.683
3rd:  11.9 -17.3 1.112 0.990 1.248 1.047 0.909 1.206 1.246 0.970 1.602
2nd:   7.8 -11.9 1.030 0.939 1.130 0.992 0.882 1.115 1.080 0.876 1.331




4th:  17.3 -48.0 1.144 0.991 1.322 1.079 0.874 1.332 1.300 1.019 1.659 *
3rd:  11.9 -17.3 1.081 0.959 1.220 1.099 0.915 1.319 1.085 0.897 1.312
2nd:   7.8 -11.9 0.965 0.871 1.070 0.933 0.794 1.096 0.988 0.836 1.167




4th:  17.3 -48.0 1.175 1.035 1.334 * 1.143 0.962 1.358 1.345 1.057 1.712 *
3rd:  11.9 -17.3 1.108 0.984 1.247 1.170 0.992 1.380 1.076 0.864 1.340
2nd:   7.8 -11.9 1.018 0.926 1.119 0.937 0.802 1.094 1.163 0.988 1.369
1st:    2.2 -7.8 1 . . 1 . . 1 . .
* : p  < 0.05
†: Adjusted odds ratios(ORs) and 95% confidence intervals (Cls) for cough symptoms relative to the concentration of PM2.5, adjusted for sex, age, BMI, temperature,
rain and seasonality.
Adjusted odds ratios and 95% confidence intervals for cough symptoms associated with PM2.5 concentration at various
lags of exposure in the single-pollutant model
